Stocks closed up on Tuesday but were indicated to open lower Wednesday morning. The Dow Jones industrials and S&P 500 have recovered more than half of their bear market losses, and investors have been caught off guard in many of the downward and upward moves. Many of those same investors are now looking for any new ideas about how to be best positioned for the rest of 2020.

24/7 Wall St. reviews dozens of analyst research reports each day of the week. Our goal is to look for new ideas for long-term investors and short-term traders alike. Many upgrades, downgrades, reiterations and initiations take place regardless of the daily market volatility. Some analyst calls cover stocks to buy while others cover stocks to sell or avoid.

Many analysts have lowered their target prices in recent weeks. That is true even in many analyst upgrades are coming with lower price targets. Yet, there are still many traditional analyst upgrades and reiterations, as if things were still close to normal. Remember that no single analyst report should be used as a sole basis for any buying or selling decision.

Consensus analyst target prices are from Refinitiv. These are the top analyst calls tracked for Wednesday, April 15, 2020.

Air Products & Chemicals Inc. (NYSE: APD) was raised to Outperform from Market Perform with a $262 price target (versus a $220.79 prior close) at Bernstein.

Akamai Technologies Inc. (NASDAQ: AKAM) was maintained as Neutral but the price target was raised to $115 from $100 (versus a $100.50 close) at Nomura/Instinet.

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) was raised to Overweight from Neutral with a $60 price target (versus a $36.77 close) at Cantor Fitzgerald.

Campbell Soup Co. (NYSE: CPB) was raised to Overweight from Neutral and the price target was raised to $55 from $48 (versus a $50.07 close) at Piper Sandler.

Cardinal Health Inc. (NYSE: CAH) was named as the Bull of the Day at Zacks, which said that this company provides personal protection equipment to hospitals nationwide. Shares most recently closed at $50.69 and have a consensus price target of $56.00.

Carlyle Group Inc. (NASDAQ: CG) was raised to Buy from Neutral with a $34 price target (versus a $24.01 close) at Citigroup.

Charles Schwab Corp. (NYSE: SCHW) was downgraded to Neutral from Buy at Citigroup.

Ford Motor Co. (NYSE: F) was started with a Neutral rating at Goldman Sachs. Ford stock closed up 2.5% at $5.29 ahead of the call, with a $6.41 consensus price target.

General Motors Co. (NYSE: GM) was started with a Neutral rating at Goldman Sachs. Shares of GM closed down 0.13% at $22.98 ahead of the call, with a $36.50 consensus price target.

Hilton Worldwide Holdings Inc. (NYSE: HLT) was named as the Zacks Bear of the Day stock. The firm said that this hospitality giant has withdrawn 2020 guidance amid the coronavirus pandemic. Shares last closed at $70.01, with a consensus price target of $83.68.

Invesco Ltd. (NYSE: IVZ) was downgraded to Sell from Neutral at Citigroup.

Jack in the Box Inc. (NASDAQ: JACK) was maintained as Outperform but its price target was cut to $67 from $100 (versus a $44.33 close) at Wedbush Securities.

JD.com Inc. (NASDAQ: JD) was raised to Overweight from Equal Weight with a $51 price target (versus a $43.86 close) at Morgan Stanley.

Johnson & Johnson (NYSE: JNJ) was reiterated as Outperform and its price target was raised to $157 from $153 (versus a $146.03 close) at Raymond James.

LendingTree Inc. (NASDAQ: TREE) was raised to Buy from Hold but the price target was lowered to $250 at SunTrust Robinson Humphrey, while Needham maintained its Buy rating but cut its price target to $220. Shares closed up 4.5% at $198.72 ahead of lowering its expectations.

Marvell Technology Group Ltd. (NASDAQ: MRVL) was maintained as Buy and its price target was cut to $28 from $29 (versus a $25.53 close) at Needham.

Mastercard Inc. (NYSE: MA) was downgraded to Hold from Buy and the price target was cut to $275 from $290 at Jefferies. Mastercard stock closed up 2.8% at $270.72 ahead of the call, with a $306.83 consensus target price, but it was indicated down almost 3% at $270.72 on Wednesday morning.

Moderna Inc. (NASDAQ: MRNA) was reiterated as Outperform and its price target was raised to $43 from $31 (versus a $34.66 close) at Oppenheimer.

Netflix Inc. (NASDAQ: NFLX) was reiterated as Buy and its price target was raised to $490 from $425 at Pivotal Research. This is a new street-high target, after the stock closed up over 4% at $413.55.

Peloton Interactive Inc. (NASDAQ: PTON) was started with a Buy rating and a $38 price target (versus a $31.88 close) at Roth Capital.

Raytheon Technologies Corp. (NYSE: RTX) was reinstated as Buy with a $76 price target (versus a $65.07 close) at Goldman Sachs.

RealReal Inc. (NASDAQ: REAL) was maintained as Buy but the price target was cut to $13 from $15 (versus a $7.99 close) at Nomura/Instinet. KeyBanc Capital Markets maintained it as Overweight but lowered its price target to $20 from $31.

Target Corp. (NYSE: TGT)) was raised to Outperform from Market Perform and its price target was raised to $125 from $115 at BMO Capital Markets. Target stock closed up 3.5% at $108.38 on Tuesday, with a $123.97 consensus price target.

Teladoc Health Inc. (NYSE: TDOC) was maintained as Hold but the price target was raised to $144 from $118 at SunTrust Robinson Humphrey. KeyBanc Capital Markets reiterated it as Overweight and raised its price target to $180 from $145.

Tesla Inc. (NASDAQ: TSLA) was started with a Buy rating and an $864 price target at Goldman Sachs. Tesla stock closed up 9% at $709.89 on Tuesday, and the shares were indicated up over 5% at $750.00 on Wednesday.

Visa Inc. (NYSE: V) was downgraded to Hold from Buy and the price target was cut to $180 from $190 at Jefferies. Visa stock closed up 3.3% at $174.62 ahead of the call, with a $199.06 consensus target price, but it was indicated down 3% at $169.50 on Wednesday morning.

Tuesday’s top analyst upgrades and downgrades included AIG, Atlassian, Chubb, Deere, Hecla Mining, ITT, Netflix, Roku, Splunk, Square, Tesla, Workday and many more.

Get Our Free Investment Newsletter

I have read, and agree to the Terms of Use

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.